ATL trio takes top spot in bid for leadership

Article

ATL is pushing its R&D throttle full forward in a bid to breakout from what it considers four-way technological parity at thetop of the high-end ultrasound field. A trio of top-level managershas been appointed to provide the administrative punch

ATL is pushing its R&D throttle full forward in a bid to breakout from what it considers four-way technological parity at thetop of the high-end ultrasound field. A trio of top-level managershas been appointed to provide the administrative punch behindthis effort, said Dennis C. Fill, chairman and CEO of ATL's parentWestmark International.

Fill was appointed chairman and president of ATL in Bothell,WA, last month. At the same time, two former ATL presidents, AllenW. Guisinger and Eugene A. Larson, were named executive vice presidentsin charge of marketing and R&D, respectively (SCAN 1/16/91).

"Both (Guisinger and Larson) were strong presidents ofATL, and both have fields of particular expertise in marketingand technology. The three of us have worked together very closelyfor a number of years. We really are a trio," Fill told SCAN.

Two medical equipment companies--ATL and patient monitoringmanufacturer Spacelabs--function as stand-alone operating unitsunder the Westmark umbrella. In the five years since these businesseswere spun off from Squibb, Spacelabs has achieved a leading technologicalposition in its field while ATL has pulled up even with Acuson,Hewlett-Packard and Toshiba, Fill said.

Westmark's decision to concentrate additional executive resourcesin ATL was based on the premise that more can be gained in thisbusiness through a concerted competitive effort. The parent companyhas boosted R&D expenditures at ATL despite groans from WallStreet, and will continue to direct more funds and attention toultrasound product upgrades and new generations of equipment,he said.

"During the last 12 months, we have accelerated our R&Dspending in both sides of our business, but particularly on theATL side," Fill said. "The reorganization will allowthe three of us to bring greater clout to this effort than anyone of us could have alone."

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.